| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
222,500 |
|
|
Indirect Shares
|
85,622 |
|
|
| Direct
Value |
$10,410,775 |
|
|
|
Indirect Value
|
$4,006,253 |
|
|
| Total
Shares |
308,122 |
|
|
| Total
Value |
$14,417,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -300.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-08-08 |
222,500 |
2024-08-08 |
85,622 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• – – |
2017-12-01 |
4 |
A |
$19.12 |
$509,873 |
D/D |
26,667 |
133,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• – – |
2017-12-21 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
148,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-01 |
4 |
AS |
$67.28 |
$1,040,400 |
D/D |
(15,000) |
148,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-01 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
163,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-04 |
4 |
D |
$67.13 |
$49,743 |
D/D |
(741) |
147,819 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-09-01 |
4 |
D |
$56.67 |
$41,992 |
D/D |
(741) |
146,531 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-12-01 |
4 |
D |
$38.33 |
$28,403 |
D/D |
(741) |
145,790 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
OE |
$1.81 |
$38,915 |
D/D |
21,500 |
167,290 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-03-01 |
4 |
D |
$39.97 |
$29,898 |
D/D |
(748) |
166,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-04-29 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
186,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-04-29 |
4 |
AS |
$42.03 |
$840,600 |
D/D |
(20,000) |
166,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-01 |
4 |
D |
$35.57 |
$26,357 |
D/D |
(741) |
165,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-17 |
4 |
AS |
$46.00 |
$920,000 |
D/D |
(20,000) |
165,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-17 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
185,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-09-01 |
4 |
D |
$46.21 |
$34,195 |
D/D |
(740) |
165,061 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-01 |
4 |
D |
$71.65 |
$53,093 |
D/D |
(741) |
164,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
OE |
$1.81 |
$14,480 |
D/D |
8,000 |
172,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-03-02 |
4 |
D |
$52.74 |
$41,876 |
D/D |
(794) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-19 |
4 |
AS |
$65.16 |
$280,644 |
D/D |
(4,307) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-19 |
4 |
OE |
$1.81 |
$7,796 |
D/D |
4,307 |
175,833 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
OE |
$1.81 |
$19,354 |
D/D |
10,693 |
182,219 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
AS |
$65.28 |
$698,039 |
D/D |
(10,693) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
OE |
$1.81 |
$31,268 |
D/D |
17,275 |
188,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
AS |
$63.57 |
$1,117,266 |
D/D |
(17,275) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-02 |
4 |
D |
$66.26 |
$51,617 |
D/D |
(779) |
170,747 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
